Direct Effectors for G Alpha 0 - Joseph Jordan

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute on Drug Abuse (NIDA)
Type: Individual Predoctoral NRSA for M.D./Ph.D. Fellowships (ADAMHA) (F30)
Project #: 5F30DA005798-05
Application #: 6362801
Study Section: Human Development Research Subcommittee (NIDA)
Program Officer: Babecki, Beth

Project Start: 2001-03-01
Project End
Budget Start: 2001-03-01
Budget End: 2002-02-28
Support Year: 5
Fiscal Year: 2001
Total Cost: $24,185
Indirect Cost

Institution

Name: Mount Sinai School of Medicine
Department: Pharmacology
Type: Schools of Medicine
DUNS #: 114400633

City: New York
State: NY
Country: United States
Zip Code: 10029

Related projects


NIH 2001 F30 DA	Direct Effectors for G Alpha 0 Jordan, Joseph D. / Mount Sinai School of Medicine	$24,185
NIH 2000 F30 DA	Direct Effectors for G Alpha 0 Jordan, Joseph D. / Mount Sinai School of Medicine	$22,245
NIH 1999 F30 DA	Direct Effectors for G Alpha 0 Jordan, Joseph D. / Mount Sinai School of Medicine
NIH 1998 F30 DA	Direct Effectors for G Alpha 0 Jordan, Joseph D. / Mount Sinai School of Medicine
NIH 1997 F30 DA	Direct Effectors for G Alpha 0 Jordan, Joseph D. / Mount Sinai School of Medicine

Publications

Pagano, Mario; Jordan, J Dedrick; Neves, Susana R et al. (2008) Galphao/i-stimulated proteosomal degradation of RGS20: a mechanism for temporal integration of Gs and Gi pathways. Cell Signal 20:1190-7

Comments

Be the first to comment on Joseph Jordan's grant